1. Home
  2. LVRO vs ORIC Comparison

LVRO vs ORIC Comparison

Compare LVRO & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lavoro Limited

LVRO

Lavoro Limited

N/A

Current Price

$0.63

Market Cap

112.6M

Sector

Finance

ML Signal

N/A

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$8.27

Market Cap

783.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LVRO
ORIC
Founded
2017
2014
Country
Brazil
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.6M
783.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LVRO
ORIC
Price
$0.63
$8.27
Analyst Decision
Sell
Strong Buy
Analyst Count
3
12
Target Price
$1.88
$19.50
AVG Volume (30 Days)
14.0K
1.5M
Earning Date
02-02-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,667,345,189.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$11.45
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$3.90
52 Week High
$5.60
$14.93

Technical Indicators

Market Signals
Indicator
LVRO
ORIC
Relative Strength Index (RSI) 29.70 26.04
Support Level $0.61 $7.98
Resistance Level $0.65 $8.61
Average True Range (ATR) 0.09 0.68
MACD 0.01 -0.16
Stochastic Oscillator 8.11 6.63

Price Performance

Historical Comparison
LVRO
ORIC

About LVRO Lavoro Limited

Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: